Lumryz 13551-0004-07
Generic: Sodium Oxybate
- Manufacturer
- Avadel Cns Pharmaceuticals, Llc
- Dosage Form
- For Suspension, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- May 1, 2023
- Listing Expires
- December 31, 2026
- Application
- NDA214755
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sodium Oxybate | 9 g/1 |
Drug Class
Central Nervous System Depressant [EPC]Central Nervous System Depression [PE]Decreased Central Nervous System Organized Electrical Activity [PE]
Selected Package
13551-0004-07Selected7 PACKET in 1 CARTON (13551-004-07) / 1 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET
Other packages for this product(1)
30 PACKET in 1 CARTON (13551-004-30) / 1 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET